quinoxalines has been researched along with formaldehyde in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (11.11) | 18.7374 |
1990's | 12 (44.44) | 18.2507 |
2000's | 11 (40.74) | 29.6817 |
2010's | 1 (3.70) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrows, TH; Benkovic, PA; Benkovic, SJ; Chrzanowski, L; Farina, PR | 1 |
Frederick, M; Kallen, RG; Tsuzynski, GP | 1 |
Gilevich, MIu | 1 |
Hunter, JC; Singh, L | 1 |
Goettl, VM; Larson, AA | 1 |
Keana, JF; Kest, B; Liebeskind, JC; Marek, P; Vaccarino, AL; Weber, E | 1 |
Keana, JF; Lutfy, K; Weber, E | 1 |
Keana, JF; Kwon, IS; Lutfy, K; Marek, P; Sadowski, B; Weber, E | 1 |
Lutfy, K; Shen, KZ; Weber, E; Woodward, RM | 1 |
Chaplan, SR; Malmberg, AB; Yaksh, TL | 1 |
Lutfy, K; Weber, E | 1 |
Deverill, M; Hoo, KH; Iyengar, S; Li, DL; Ornstein, PL; Simmons, RM | 1 |
Gyermek, L; Kawasaki-Yatsugi, S; Lee, C; Nishiyama, T; Yamaguchi, T | 3 |
Tao, YX; Zhao, ZQ | 1 |
Aguirre-Bañuelos, P; Granados-Soto, V | 1 |
Nishiyama, T | 1 |
Johns, RA; Tao, YX | 1 |
Castañeda-Hernández, G; Granados-Soto, V; Ortiz, MI; Rosas, R; Torres-López, JE; Vidal-Cantú, GC | 1 |
Ambriz-Tututi, M; Granados-Soto, V; Urquiza-Marín, H; Velázquez-Zamora, DA | 1 |
Castañeda-Hernández, G; Granados-Soto, V; Lozano-Cuenca, J | 1 |
Granados-Soto, V; Torres-López, JE | 1 |
Bae, HB; Choi, JI; Chung, SS; Chung, ST; Jeong, CY; Jeong, SW; Kim, CM; Kim, SJ; Yoo, KY; Yoon, MH | 1 |
An, TH; Bae, HB; Choi, JI; Chung, SS; Chung, ST; Jeong, CY; Jeong, SW; Kim, CM; Kim, SJ; Yoo, KY; Yoon, MH | 1 |
Araiza-Saldaña, CI; Bermúdez-Ocaña, DY; Granados-Soto, V; Pérez-Severiano, F; Reyes-García, G | 1 |
Cervantes-Durán, C; Espinosa de los Monteros-Zuñiga, A; Godínez-Chaparro, B; Izquierdo, T; Lozada, MC | 1 |
27 other study(ies) available for quinoxalines and formaldehyde
Article | Year |
---|---|
Studies on models for tetrahydrofolic acid. 7. Reactions and mechanisms of tetrahydroquinoxaline derivatives at the formaldehyde level of oxidation.
Topics: Animals; Dogs; Formaldehyde; Models, Chemical; Oxidation-Reduction; Quinoxalines; Tetrahydrofolates | 1976 |
Tetrahydrofolic acid model studies. II. Equilibrium and kinetic studies of the reaction of tetrahydroquinoline and tetrahydroquinoxaline derivatives with formaldehyde, carbinolamine, imidazolidine, and hexahydropyrimidine formation.
Topics: Formaldehyde; Imidazoles; Kinetics; Models, Chemical; Pyrimidines; Quinolines; Quinoxalines; Tetrahydrofolates | 1975 |
[Selection of the method of treating the cavity of the fibrous capsule during echinococcectomy].
Topics: Animals; Dogs; Echinococcosis, Pulmonary; Echinococcus; Formaldehyde; Humans; Intraoperative Care; Iodine; Lung; Picrates; Quinoxalines; Thiosulfates | 1984 |
Role of excitatory amino acid receptors in the mediation of the nociceptive response to formalin in the rat.
Topics: Analgesics; Animals; Formaldehyde; Inflammation; Male; N-Methylaspartate; Nociceptors; Pain Measurement; Pipecolic Acids; Pyrrolidinones; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, Glutamate; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate | 1994 |
Antinociception induced by 3-((+-)-2-carboxypiperazin-4-yl)-propyl-1- phosphonic acid (CPP), an N-methyl-D-aspartate (NMDA) competitive antagonist, plus 6,7-dinitroquinoxaline-2,3-dione (DNQX), a non-NMDA antagonist, differs from that induced by MK-801 pl
Topics: Animals; Dizocilpine Maleate; Formaldehyde; Injections, Spinal; Male; Mice; Pain; Pain Measurement; Piperazines; Quinoxalines; Receptors, N-Methyl-D-Aspartate | 1994 |
NMDA receptor antagonists, MK-801 and ACEA-1011, prevent the development of tonic pain following subcutaneous formalin.
Topics: Analgesics; Animals; Behavior, Animal; Dizocilpine Maleate; Foot; Formaldehyde; Injections, Subcutaneous; Male; Mice; Mice, Inbred Strains; Pain; Quinoxalines; Receptors, N-Methyl-D-Aspartate | 1993 |
ACEA-1011, a novel NMDA receptor/glycine site antagonist, produces antinociception but not tolerance in the formalin test in mice.
Topics: Analgesics; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Excitatory Amino Acid Agonists; Formaldehyde; Male; Mice; Pain Measurement; Quinoxalines; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate | 1995 |
Differential sensitivity of mice bred for stress-induced analgesia to morphine and ACEA-1011 in the formalin test.
Topics: Analgesia; Analgesics; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Formaldehyde; Male; Mice; Mice, Inbred Strains; Morphine; Naloxone; Narcotic Antagonists; Pain Measurement; Quinoxalines; Stress, Psychological; Swimming | 1996 |
Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test.
Topics: Animals; Behavior, Animal; Binding, Competitive; Brain Chemistry; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Tolerance; Electrophysiology; Excitatory Amino Acid Antagonists; Female; Formaldehyde; Gene Expression; Locomotion; Male; Mice; Morphine; Motor Activity; Narcotics; Nociceptors; Oocytes; Quinoxalines; Radioligand Assay; Rats; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Xenopus laevis | 1996 |
Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat.
Topics: 2-Amino-5-phosphonovalerate; Analgesics; Animals; Dextromethorphan; Dextrorphan; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Formaldehyde; Hyperalgesia; Injections, Spinal; Ketamine; Male; Memantine; Morphine; Pain; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Spinal Cord; Spinal Nerves; Touch | 1997 |
Tolerance develops to the antinociceptive and motor impairing effects of ACEA-1416, a NMDA receptor antagonist, in the formalin and rotarod test in mice.
Topics: Analgesics; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Formaldehyde; Male; Mice; Pain Measurement; Postural Balance; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Time Factors | 1998 |
Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat.
Topics: Animals; Benzodiazepines; Excitatory Amino Acid Antagonists; Formaldehyde; Humans; Isoquinolines; Male; Pain Threshold; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Kainic Acid; Tetrazoles | 1998 |
The spinal antinociceptive effects of a novel competitive AMPA receptor antagonist, YM872, on thermal or formalin-induced pain in rats.
Topics: Analgesics, Non-Narcotic; Animals; Dose-Response Relationship, Drug; Formaldehyde; Imidazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Spinal Cord | 1999 |
NMDA receptors mediating Fos expression in rat spinal cord induced by subcutaneous injection of formalin.
Topics: 2-Amino-5-phosphonovalerate; Animals; Dose-Response Relationship, Drug; Formaldehyde; Male; Neurons; Nociceptors; Pain; Proto-Oncogene Proteins c-fos; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Spinal Cord | 1998 |
The systemically administered competitive AMPA receptor antagonist, YM872, has analgesic effects on thermal or formalin-induced pain in rats.
Topics: Analgesics, Non-Narcotic; Animals; Behavior, Animal; Binding, Competitive; Formaldehyde; Hot Temperature; Imidazoles; Injections, Intraperitoneal; Male; Motor Activity; Nociceptors; Pain; Pain Measurement; Quinoxalines; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, AMPA | 1999 |
Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive action of meloxicam in the formalin test.
Topics: Analgesics, Non-Narcotic; Animals; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Formaldehyde; Guanylate Cyclase; Meloxicam; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Pain; Pain Measurement; Quinoxalines; Rats; Rats, Wistar; Thiazines; Thiazoles | 2000 |
Interaction between intrathecal morphine and glutamate receptor antagonists in formalin test.
Topics: 2-Amino-5-phosphonovalerate; Analgesics, Opioid; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Formaldehyde; Injections, Spinal; Male; Morphine; Motor Activity; Pain; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate | 2000 |
Synergistic analgesic effects of intrathecal midazolam and NMDA or AMPA receptor antagonists in rats.
Topics: 2-Amino-5-phosphonovalerate; Adjuvants, Anesthesia; Animals; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Antagonists; Formaldehyde; Imidazoles; Male; Midazolam; Neuroprotective Agents; Pain Measurement; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, GABA-A; Receptors, N-Methyl-D-Aspartate | 2001 |
Activation and up-regulation of spinal cord nitric oxide receptor, soluble guanylate cyclase, after formalin injection into the rat hind paw.
Topics: Animals; Behavior, Animal; Enzyme Activation; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Formaldehyde; Guanylate Cyclase; Hindlimb; Hyperalgesia; Inflammation; Injections, Intraperitoneal; Injections, Spinal; Male; Neurons; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Oxadiazoles; Pain Measurement; Protein Subunits; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, N-Methyl-D-Aspartate; Soluble Guanylyl Cyclase; Spinal Cord; Tissue Distribution; Up-Regulation | 2002 |
Role of the nitric oxide-cyclic GMP-K+ channel pathway in the antinociception induced by atrial natriuretic peptide (ANP) and diclofenac.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Atrial Natriuretic Factor; Charybdotoxin; Cyclic GMP; Diclofenac; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Formaldehyde; Glyburide; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Pain Measurement; Potassium Channels; Quinoxalines; Rats; Rats, Wistar; Tolbutamide | 2002 |
Analysis of the mechanism underlying the peripheral antinociceptive action of sildenafil in the formalin test.
Topics: Analgesics; Animals; Apamin; Charybdotoxin; Cyclic GMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Formaldehyde; Guanylate Cyclase; Injections, Subcutaneous; Oxadiazoles; Pain; Pain Measurement; Piperazines; Potassium Channel Blockers; Purines; Quinoxalines; Rats; Rats, Wistar; Sildenafil Citrate; Sulfones; Tetraethylammonium; Time Factors; Tolbutamide | 2005 |
Peripheral and spinal mechanisms of antinociceptive action of lumiracoxib.
Topics: Analgesics; Animals; Apamin; Behavior, Animal; Charybdotoxin; Diclofenac; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Formaldehyde; Glyburide; Guanylate Cyclase; Hindlimb; Injections, Spinal; Injections, Subcutaneous; Methiothepin; Naloxone; Neurotoxins; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Organic Chemicals; Oxadiazoles; Pain; Pain Measurement; Quinoxalines; Rats; Rats, Wistar; Scorpion Venoms | 2005 |
Peripheral participation of the phosphodiesterase 3 on formalin-evoked nociception.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cyclic Nucleotide Phosphodiesterases, Type 3; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Formaldehyde; Guanylate Cyclase; Injections, Subcutaneous; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxadiazoles; Pain; Pain Measurement; Quinoxalines; Rats; Rats, Wistar; Tetrahydroisoquinolines; Time Factors | 2005 |
Lack of the nitric oxide-cyclic GMP-potassium channel pathway for the antinociceptive effect of intrathecal zaprinast in a rat formalin test.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Analgesics; Animals; Cyclic GMP; Formaldehyde; Glyburide; Injections, Spinal; Male; Nitric Oxide; omega-N-Methylarginine; Oxadiazoles; Pain; Pain Measurement; Phosphodiesterase Inhibitors; Potassium Channels; Purinones; Quinoxalines; Rats; Rats, Sprague-Dawley; Signal Transduction | 2005 |
Evaluation of interaction between intrathecal adenosine and MK801 or NBQX in a rat formalin pain model.
Topics: Adenosine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Disease Models, Animal; Dizocilpine Maleate; Drug Synergism; Excitatory Amino Acid Antagonists; Formaldehyde; Injections, Spinal; Male; N-Methylaspartate; Pain; Quinoxalines; Rats; Rats, Sprague-Dawley | 2005 |
Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats.
Topics: Analgesia; Animals; Blood Glucose; Body Weight; Carbazoles; Cyclic GMP-Dependent Protein Kinases; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Formaldehyde; Guanylate Cyclase; Indoles; Injections, Spinal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxadiazoles; Pain; Pain Measurement; Phosphodiesterase Inhibitors; Piperazines; Potassium Channel Blockers; Purines; Quinoxalines; Rats; Rats, Wistar; Sildenafil Citrate; Streptozocin; Sulfones; Time Factors | 2005 |
Mechanisms underlying the antinociceptive effect of mangiferin in the formalin test.
Topics: Analgesics; Animals; Capsaicin; Formaldehyde; Glyburide; Male; Naloxone; Naltrexone; NG-Nitroarginine Methyl Ester; Nociception; Quinoxalines; Rats; Rats, Wistar; Serotonin; Xanthones | 2013 |